Related Experiment Video

Updated: Mar 30, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.6K

Interferon-free combination therapies for the treatment of hepatitis C: current insights

Jacinta A Holmes1, Alexander J Thompson1

  • 1Department of Gastroenterology, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia.

Hepatic Medicine : Evidence and Research
|November 21, 2015
PubMed

Insights

Direct-acting antiviral agents have transformed hepatitis C virus (HCV) treatment, offering effective, oral, interferon-free options. This review covers new DAA classes and combinations for chronic HCV infection in various patient groups.

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • The hepatitis C virus (HCV) treatment landscape has undergone significant evolution in recent years.
  • Direct-acting antiviral (DAA) agents have revolutionized therapy by targeting specific viral proteins.
  • Highly effective, well-tolerated, oral, interferon-free regimens are now available.

Purpose of the Study:

  • To review the different classes of direct-acting antiviral (DAA) agents for HCV treatment.
  • To discuss various DAA combinations in advanced development for chronic HCV infection.
  • To focus on DAA regimens tailored for specific patient populations.

Main Methods:

  • Literature review of recent advancements in HCV therapeutics.
  • Analysis of direct-acting antiviral (DAA) agents targeting HCV lifecycle.
  • Examination of combination therapies and their efficacy in clinical development.

Main Results:

  • DAAs targeting nonstructural HCV proteins and essential host factors have emerged.
  • Numerous DAA combinations are in advanced stages of development.
  • Treatment strategies are being refined for diverse patient groups.

Conclusions:

  • Direct-acting antiviral (DAA) therapy represents a paradigm shift in managing HCV infection.
  • The development of novel DAA combinations promises improved outcomes.
  • Personalized treatment approaches are crucial for optimizing HCV eradication in all patients.
Keywords:
HCV therapydirect-acting antiviralsinterferon-free

More Related Videos

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.5K

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
24
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
37
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

1.8K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K